Clinical Trial Update: A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase I/II study evaluating hypofractionated proton therapy for stage II-III non-small cell lung cancer. The trial is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Proton Collaborative Group | Conditions: Lung Neoplasms | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING